Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aviram

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid loweringS H Wilson, R D Simari, P J Best, et al.
Drugs Under Experimental and Clinical Research|September 13, 2002
Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.
Pediatric Pulmonology|October 3, 2000
Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat testsA Augarten, H Shmilovich, R Doolman, et al.
Pediatric Transplantation|September 19, 2001
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patientsA Augarten, H Akons, M Aviram, et al.
Clinical and Experimental Medicine|November 5, 2003
Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat testsA Augarten, H Berman, M Aviram, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentationsE Kerem, N Rave-Harel, A Augarten, et al.
The European Respiratory Journal|January 15, 2011
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosisM Wilschanski, L L Miller, D Shoseyov, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid loweringS H Wilson, R D Simari, P J Best, et al.
Drugs Under Experimental and Clinical Research|September 13, 2002
Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.
Pediatric Pulmonology|October 3, 2000
Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat testsA Augarten, H Shmilovich, R Doolman, et al.
Pediatric Transplantation|September 19, 2001
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patientsA Augarten, H Akons, M Aviram, et al.
Clinical and Experimental Medicine|November 5, 2003
Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat testsA Augarten, H Berman, M Aviram, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentationsE Kerem, N Rave-Harel, A Augarten, et al.
The European Respiratory Journal|January 15, 2011
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosisM Wilschanski, L L Miller, D Shoseyov, et al.
Pageof 27